Diagnosis and the debatable issues of the treatment of heart failure with preserved ejection fraction

Heart failure with preserved fraction (HFpEF) amount for a half of the general heart failure and increasing progressively. In this review we discuss the issues of pathogenesis of HFpEF, illuminated in the recent literature in the last years. Considering the heterogeneity of the pathophysiology of th...

Full description

Saved in:
Bibliographic Details
Published inCardioSomatika Vol. 9; no. 4; pp. 32 - 37
Main Authors Akhilgova, Z. M, Kurkina, M. V, Dzhioeva, Z. R, Puhaeva, A. A, Avtandilov, A. G
Format Journal Article
LanguageEnglish
Published Concilium Medicum 15.12.2018
Subjects
heart failure with preserved fraction
pathophysiology
prevention
treatment
Online AccessGet full text

Cover

More Information
Summary:Heart failure with preserved fraction (HFpEF) amount for a half of the general heart failure and increasing progressively. In this review we discuss the issues of pathogenesis of HFpEF, illuminated in the recent literature in the last years. Considering the heterogeneity of the pathophysiology of this syndrome and the results of large-scale studies conducted nowadays, it considers the debatable treatment issues of the applying different drugs in the prevention of HFpEF.
ISSN:2221-7185
2658-5707
DOI:10.26442/22217185.2018.4.000013